Glick R, Hoying J, Cerullo L, Perlman S
Neurosurgery. 1987 Jun;20(6):969-74. doi: 10.1227/00006123-198706000-00027.
Phenylpropanolamine (PPA) is the major ingredient in more than 70 over-the-counter preparations including diet pills, nasal decongestants, and the legal "look-alike" stimulants. Structurally and functionally similar to amphetamine and ephedrine, PPA has recently been associated with several neurological manifestations including psychosis, stroke, severe headache, seizures, and intracerebral hematoma. We report a case of intracerebral hematoma and subarachnoid hemorrhage in a young woman with angiographic and biopsy-proven vasculitis of the central nervous system (CNS) induced by PPA in her diet pills. From review of the literature, we distinguish drug-induced vasculitis as a separate entity from primary CNS vasculitis, both clinically and pathologically. This report should alert physicians, in general, to this potentially fatal side effect of PPA, a commonly used over-the-counter drug. Also, neurosurgeons in particular should consider the possibility of drug-induced vasculitis when faced with cases of intracerebral or subarachnoid hemorrhage without apparent cause.
苯丙醇胺(PPA)是70多种非处方制剂中的主要成分,这些制剂包括减肥药、鼻减充血剂以及合法的“类兴奋剂”。PPA在结构和功能上与苯丙胺和麻黄碱相似,最近它与多种神经学表现有关,包括精神病、中风、严重头痛、癫痫发作和脑内血肿。我们报告了一例年轻女性发生脑内血肿和蛛网膜下腔出血的病例,该病例经血管造影和活检证实为其减肥药中的PPA诱发的中枢神经系统(CNS)血管炎。通过文献回顾,我们从临床和病理方面将药物性血管炎与原发性CNS血管炎区分开来作为一个单独的实体。本报告总体上应提醒医生注意PPA这种常用非处方药的这种潜在致命副作用。此外,神经外科医生在面对无明显病因的脑内或蛛网膜下腔出血病例时,尤其应考虑药物性血管炎的可能性。